Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RISPERIDONE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 973 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Vittorio Mapelli
      Costo ed efficacia del trattamento della schizofrenia con olanzapina e risperidone: evidenze per il SSN

      Farmeconomia e percorsi terapeutici
    2. Giorgio D'Allio; fernando Rutto; Michela Coppi; Luca Guidi
      Livello di dipendenza dai Servizi Territoriali e costi relativi al trattamento della schizofrenia

      Farmeconomia e percorsi terapeutici
    3. Egidio Filippelli; Giovanni Biricolti; Cinzia Scarano; Federico Russo; Lucio Luciano
      Il trattamento dei disturbi psicotici con olanzapina, risperidone e neurolettici tipici: una valutazione comparativa di costo/efficacia in una realtÓ psichiatrica locale

      Farmeconomia e percorsi terapeutici
    4. Smith, RC; Infante, M; Singh, A; Khandat, A
      The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    5. Ghaemi, SN
      On defining 'mood stabilizer'

      BIPOLAR DISORDERS
    6. Peuskens, J; De Hert, M; Jones, M
      The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safety

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    7. Procyshyn, RM; Flynn, S
      Discharge prescribing practices: Comparing a research ward to general treatment wards

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    8. Emsley, R; Oosthuizen, P; Niehaus, D; Stein, D
      Anxiety symptoms in schizophrenia: the need for heightened clinician awareness

      PRIMARY CARE PSYCHIATRY
    9. Wolters, EC; Berendse, HW
      Management of psychosis in Parkinson's disease

      CURRENT OPINION IN NEUROLOGY
    10. Gobbi, G; Pulvirenti, L
      Long-term treatment with dozapine in an adult with autistic disorder accompanied by aggressive behaviour

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    11. Purdon, SE; Malla, A; Labelle, A; Lit, W
      Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    12. Khullar, A; Chue, P; Tibbo, P
      Quetiapine and obsessive-compulsive symptoms (OCS): case report and reviewof atypical antipsychotic-induced OCS

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    13. Tauscher, J; Kapur, S
      Choosing the right dose of antipsychotics in schizophrenia - Lessons from neuroimaging studies

      CNS DRUGS
    14. Campbell, S; Stephens, S; Ballard, C
      Dementia with lewy bodies - Clinical features and treatment

      DRUGS & AGING
    15. Hirose, S; Ashby, CR; Mills, MJ
      Effectiveness of ECT combined with risperidone against aggression in schizophrenia

      JOURNAL OF ECT
    16. Escamilla, M
      Diagnosis and treatment of mood disorders that co-occur with schizophrenia

      PSYCHIATRIC SERVICES
    17. Noordsy, DL; O'Keefe, C; Mueser, KT; Xie, HY
      Six-month outcomes for patients who switched to olanzapine treatment

      PSYCHIATRIC SERVICES
    18. Osser, DN; Sigadel, R
      Short-term inpatient pharmacotherapy of schizophrenia

      HARVARD REVIEW OF PSYCHIATRY
    19. Salzman, C; Tune, L
      Neuroleptic treatment of late-life schizophrenia

      HARVARD REVIEW OF PSYCHIATRY
    20. Patel, JK; Caplan, B; Green, A; Tamminga, C
      First-episode psychosis: Critical management issues during the first two years

      HARVARD REVIEW OF PSYCHIATRY
    21. Schneider, LS; Tariot, PN; Lyketsos, CG; Dagerman, KS; Davis, KL; Davis, S; Hsiao, JK; Jeste, DV; Katz, IR; Olin, JT; Pollock, BG; Rabins, PV; Rosenheck, RA; Small, GW; Lebowitz, B; Lieberman, JA
      National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) - Alzheimer disease trial methodology

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    22. Madhusoodanan, S
      Introduction - Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric patients

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    23. Edell, WS; Tunis, SL
      Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    24. Reeves, RR; Mack, JE; Torres, RA
      Neuroleptic malignant syndrome during a change from haloperidol to risperidone

      ANNALS OF PHARMACOTHERAPY
    25. Miller, LJ
      Gabapentin for treatment of behavioral and psychological symptoms of dementia

      ANNALS OF PHARMACOTHERAPY
    26. Posey, DJ; Guenin, KD; Kohn, AE; Swiezy, NB; McDougle, CJ
      A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    27. Bryden, KE; Carrey, NJ; Kutcher, SP
      Update and recommendations for the use of antipsychotics in early-onset psychoses

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    28. Parraga, HC; Parraga, MI; Woodward, RL; Fenning, PA
      Quetiapine treatment of children with Tourette's syndrome: Report of two cases

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    29. Mehler, C; Wewetzer, C; Schulze, U; Warnke, A; Theisen, F; Dittmann, RW
      Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases

      EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
    30. Guarna, A; Menchi, G; Berti, G; Cini, N; Bottoncetti, A; Raspanti, S; Politi, A; Pupi, A
      Synthesis and preliminary biological characterization of a new potential I-125-radioligand for dopamine and serotonin receptors

      BIOORGANIC & MEDICINAL CHEMISTRY
    31. Erbagci, AB; Herken, H; Koyluoglu, O; Yilmaz, N; Tarakcioglu, M
      Serum IL-1 beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment

      MEDIATORS OF INFLAMMATION
    32. Barnes, TRE; Joyce, EM
      Antipsychotic drug treatment: recent advances

      CURRENT OPINION IN PSYCHIATRY
    33. Markianos, M; Hatzimanolis, J; Lykouras, L
      Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    34. Bernardo, M; Parellada, E; Lomena, F; Catafau, AM; Font, M; Gomez, JC; Lopez-Carrero, C; Gutierrez, F; Pavia, J; Salamero, M
      Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint [I-123]IBZM SPECT study

      PSYCHIATRY RESEARCH-NEUROIMAGING
    35. Aleman, A; Kahn, RS
      Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    36. Nishimura, K; Tsuka, M; Horikawa, N
      Withdrawal-emergent rabbit syndrome during dose reduction of risperidone

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    37. Gefvert, O; Lundberg, T; Wieselgren, IM; Bergstrom, M; Langstrom, B; Wiesel, FA; Lindstrom, L
      D-2 and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    38. Schreinzer, D; Frey, R; Stimpfl, T; Vycudilik, W; Berzlanovich, A; Kasper, S
      Different fatal toxicity of neuroleptics identified by autopsy

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    39. Naber, D; Karow, A
      Good tolerability equals good results: the patient's perspective

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    40. Kane, JM
      Extrapyramidal side effects are unacceptable

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    41. Kasper, S; Tauscher, J; Heiden, A
      Quetiapine: efficacy and tolerability in schizophrenia

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    42. Lynch, J; Morrison, J; Graves, N; Meddis, D; Drummond, MF; Hellewell, JSE
      The health economic implications of treatment with quetiapine: an audit oflong-term treatment for patients with chronic schizophrenia

      EUROPEAN PSYCHIATRY
    43. Mauri, MC; Laini, V; Boscati, L; Rudelli, R; Salvi, V; Orlandi, R; Papa, P
      Long-term treatment of chronic schizophrenia with risperidone: a study with plasma levels

      EUROPEAN PSYCHIATRY
    44. Silver, H; Shlomo, M
      Perception of facial emotions in chronic schizophrenia does not correlate with negative symptoms but correlates with cognitive and motor dysfunction

      SCHIZOPHRENIA RESEARCH
    45. Naber, D; Moritz, S; Lambert, M; Rajonk, F; Holzbach, R; Mass, R; Andresen, B; Frank, P; Rudiger, H; Reinhard, M; Burghard, A
      Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs

      SCHIZOPHRENIA RESEARCH
    46. Rabinowitz, J; Davidson, M
      Risperidone versus haloperidol in long-term hospitalized chronic patients in a double blind randomized trial: a post hoc analysis

      SCHIZOPHRENIA RESEARCH
    47. Ganguli, R; Brar, JS; Ayrton, Z
      Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone

      SCHIZOPHRENIA RESEARCH
    48. Rasmussen, T; Fink-Jensen, A; Sauerberg, P; Swedberg, MDB; Thomsen, C; Sheardown, MJ; Jeppesen, L; Calligaro, DO; DeLapp, NW; Whitesitt, C; Ward, JS; Shannon, HE; Bymaster, FP
      The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance

      SCHIZOPHRENIA RESEARCH
    49. Cuesta, MJ; Peralta, V; Zarzuela, A
      Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study

      SCHIZOPHRENIA RESEARCH
    50. Purdon, SE; Labelle, A; Boulay, L
      Neuropsychological change in schizophrenia after 6 weeks of clozapine

      SCHIZOPHRENIA RESEARCH
    51. Sacristan, A; Gomez, JC; Badia, X; Kind, P
      Global index of safety (GIS): A new instrument to assess drug safety

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    52. Bowie, CR; Moriarty, PJ; Harvey, PD; Parrella, M; White, L; Davis, KL
      Aggression in elderly schizophrenia patients: A comparison of nursing homeand state hospital residents

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    53. Manzanedo, C; Aguilar, MA; Rodriguez-Arias, M; Minarro, J
      Individual differences in the induction of sensitisation or tolerance to the motor effects of morphine in mice

      NEUROSCIENCE RESEARCH COMMUNICATIONS
    54. Malone, RP; Cater, J; Sheikh, RM; Choudhury, MS; Delaney, MA
      Olanzapine versus haloperidol in children with autistic disorder: An open pilot study

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    55. McClellan, J; Werry, J; Bernet, W; Arnold, V; Beitchman, J; Benson, RS; Bukstein, O; Kinlan, J; McClellan, J; Rue, D; Shaw, J; Kroeger, K
      Practice parameter for the assessment and treatment of children and adolescents with schizophrenia

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    56. Masi, G; Cosenza, A; Mucci, M; Brovedani, P
      Open trial of risperidone in 24 young children with pervasive developmental disorders

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    57. Howard, R; Ballard, C; O'Brien, J; Burns, A
      Guidelines for the management of agitation in dementia

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    58. Verma, S; Orengo, CA; Kunik, ME; Hale, D; Molinari, VA
      Tolerability and effectiveness of atypical antipsychotics in male geriatric inpatients

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    59. Cavallaro, R; Mistretta, P; Cocchi, F; Manzato, M; Smeraldi, E
      Differential efficacy of risperidone versus haloperidol in psychopathological subtypes of subchronic schizophrenia

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    60. Tsolaki, M
      Evaluation of tiapride in agitated elderly outpatients: an open study

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    61. Factor, SA; Friedman, JH; Lannon, MC; Oakes, D; Bourgeois, K
      Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial

      MOVEMENT DISORDERS
    62. Jaunay, E; Gaillac, V; Guelfi, JD
      The serotonin syndrome: what treatment and when

      PRESSE MEDICALE
    63. Burns, MJ
      The pharmacology and toxicology of atypical antipsychotic agents

      JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY
    64. Friedlander, R; Lazar, S; Klancnik, J
      Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    65. Ganesan, V; Kumar, TCR; Khanna, S
      Obsessive-compulsive disorder and psychosis

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    66. Ahmed, AG; Heigh, LM; Ramachandran, KV
      Polydipsia, psychosis, and familial psychopathology

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    67. Labelle, A; Light, M; Dunbar, F
      Risperidone treatment of outpatients with schizophrenia: No evidence of sex differences in treatment response

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    68. Procyshyn, RM; Kennedy, NB; Tse, G; Thompson, B
      Antipsychotic polypharmacy: A survey of discharge prescriptions from a tertiary care psychiatric institution

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    69. Francobandiera, G
      Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: An open study

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    70. Prior, TI
      Treatment of posttraumatic stress disorder with olanzapine

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    71. Rascol, O; Fabre, N
      Dyskinesia: L-dopa-induced and tardive dyskinesia

      CLINICAL NEUROPHARMACOLOGY
    72. Takahashi, H; Yoshida, K; Higuchi, H; Shimizu, T
      Development of parkinsonian symptoms after discontinuation of carbamazepine in patients concurrently treated with risperidone: Two case reports

      CLINICAL NEUROPHARMACOLOGY
    73. Valevski, A; Loebl, T; Keren, T; Bodinger, L; Weizman, A
      Response of catatonia to risperidone: Two case reports

      CLINICAL NEUROPHARMACOLOGY
    74. Sanders, RD
      Valproate-related edema

      CLINICAL NEUROPHARMACOLOGY
    75. Patterson, C; Gauthier, S
      Canadian consensus conference on dementia: Two years later

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    76. Esel, E; Basturk, M; Gonul, AS; Kula, M; Turan, MT; Yabanoglu, I; Sofuoglu, S
      Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients

      PSYCHONEUROENDOCRINOLOGY
    77. Yoshimura, R; Ueda, N; Nakamura, J
      Possible relationship between combined plasma concentrations of risperidone plus 9-hydroxyrisperidone and extrapyramidal symptoms - Preliminary study

      NEUROPSYCHOBIOLOGY
    78. Nilsson, M; Waters, S; Waters, N; Carlsson, A; Carlsson, ML
      A behavioural pattern analysis of hypoglutamatergic mice - effects of fourdifferent antipsychotic agents

      JOURNAL OF NEURAL TRANSMISSION
    79. Remington, G; Khramov, I
      Health care utilization in patients with schizophrenia maintained on atypical versus conventional antipsychotics

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    80. Carlsson, ML
      On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    81. Hatch, CD; Lund, BC; Perry, PJ
      Failed challenge with quetiapine after neuroleptic malignant syndrome withconventional antipsychotics

      PHARMACOTHERAPY
    82. Vieta, E; Reinares, M; Corbella, B; Benabarre, A; Gilaberte, I; Colom, F; Martinez-Aran, A; Gasto, C; Tohen, M
      Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    83. Fleming, K; Thyrum, P; Yeh, C; Vargo, DL; Potkin, SG
      Cognitive improvements in psychotic subjects treated with "Seroquel" (quetiapine fumarate): An exploratory study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    84. Silva, JACE; Alvarez, N; Mazzotti, G; Gattaz, WF; Ospina, J; Larach, V; Starkstein, S; Oliva, D; Cousins, L; Tohen, M; Taylor, CC; Wang, J; Tran, PV
      Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: Results of a multicenter, collaborative trial in Latin America

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    85. Lindenmayer, JP; Volavka, J; Lieberman, J; Sheitman, B; Citrome, L; Chakos, M; Czobor, P; Parker, B; Iskander, A
      Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: An open-label, prospective trial

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    86. Eap, CB; Bondolfi, G; Zullino, D; Savary-Cosendai, L; Powell-Golay, K; Kosel, M; Baumann, P
      Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    87. Vesce, J; Comaty, JE; Advokat, C
      Antiaggressive action of atypical antipsychotics in patients with schizophrenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    88. Keck, PE; Reeves, KR; Harrigan, EP
      Ziprasidone in the short-term treatment of patients with schizoaffective disorder: Results from two double-blind, placebo-controlled, multicenter studies

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    89. Bozikas, V; Petrikis, P; Karavatos, A
      Urinary retention caused after fluoxetine-risperidone combination

      JOURNAL OF PSYCHOPHARMACOLOGY
    90. Zhang, XY; Zhou, DF; Cao, LY; Zhang, PY; Wu, GY; Shen, YC
      Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    91. Glick, ID; Lemmens, P; Vester-Blokland, E
      Treatment of the symptoms of schizophrenia: a combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    92. Kasper, S; Rosillon, D; Duchesne, I
      Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    93. Kasper, S; Jones, M; Duchesne, I
      Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): health economic results of an international naturalistic study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    94. Butterfield, MI; Becker, ME; Connor, KM; Sutherland, S; Churchill, LE; Davidson, JRT
      Olanzapine in the treatment of post-traumatic stress disorder: a pilot study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    95. Mir, S; Taylor, D
      Atypical antipsychotics and hyperglycaemia

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    96. Licht, RW; Bysted, M; Christensen, H
      Fixed-dosed risperidone in mania: an open experimental trial

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    97. Kodesh, A; Finkel, B; Lerner, AG; Kretzmer, G; Sigal, M
      Dose-dependent olanzapine-associated leukopenia: three case reports

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    98. Schweitzer, I
      Does risperidone have a place in the treatment of nonschizophrenic patients?

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    99. Garcia-Anaya, M; Apiquian, R; Fresan, A
      Atypical anti-psychotics: review article.

      SALUD MENTAL
    100. Braus, DF; Ende, G; Weber-Fahr, W; Demirakca, T; Henn, FA
      Favorable effect on neuronal viability in the anterior cingulate gyrus dueto long-term treatment with atypical antipsychotics: An MRSI study

      PHARMACOPSYCHIATRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/19 alle ore 04:19:18